Scandion Oncology

Overcoming cancer drug resistance

Navbar
  • Research & Development
    • Pipeline
    • Clinical Development
    • Science
      • Cancer drug resistance
      • Technology Platform
      • SCO-101
  • News & Press
    • Press releases
  • Investors
    • Share information
    • Financial calendar
    • Financial Reports
      • Annual reports
      • Interim reports
    • Presentations
    • Business development
    • Analyst Coverage
    • Prospectuses
      • Subscription warrants
      • Rights Issue 2024
      • Rights Issue 2022
      • Rights Issue 2020
      • Rights Issue 2019
      • Subscription Warrant (SCOL TO 1)
      • IPO 2018
    • Corporate governance
    • General meetings
Skip to content

Presentations

22 May 2024

KOL interview on CORIST – Professor Josep Tabernero, MD, PhD

Read more about the presentation here.
16 May 2024

R&D Update May 15

Watch the R&D Update from May 15th
4 March 2024

BioStock interview w. Francois Martelet

Our clinical study and partnering strategy are jointly progressing.
28 February 2024

Q4 & Yearend Report 2023

Watch the webcast for Q4 & Yearend Report 2023.
5 February 2024

Scandion Investor/R&D Event on February 5

Watch the full presentation from the event.
24 April 2023

Swiss Biotech Day Basel, April 24-25, 2023

Swiss Biotech Day Basel, April 24-25, 2023
30 March 2023

Swiss Nordic Bio Zurich

Swiss Nordic Bio Zurich, March 30, 2023
28 November 2022

Redeye Life Science Day

Infocus interview with CEO Johnny Stilou at Redeye Life Science Day 2022.
26 October 2022

Økonomisk Ugebrev conference

Watch the presentation by acting CEO and CFO Johnny Stilou.
24 October 2022

BIO-Europe 2022

See the slide deck.
13 October 2022

Investor AW

Watch the presentation by VP Mads Aaboe Jensen.
10 October 2022

DAF visit to Scandion

See the slide deck here.
  1. Frontpage

About us

Research & Development

  • Research & Development
  • Pipeline
  • Clinical Development
  • Science

News & Press

  • Press releases
  • Other news
  • Image library items
  • Video library items

Investors

  • Investors
  • Share information
  • Financial Reports
  • Presentations
  • Analyst Coverage
  • Prospectuses
  • Corporate governance
  • Events

Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.